Linkoping, Sweden, August 31, 2022 /PR Newswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is launching a new business unit to drive innovation and product development in the field of genomics. In the future, Sectra’s enterprise diagnostic IT platform will be extended to efficiently process genomics information. This is another step in Sectra’s commitment to integrated diagnostics. This interdisciplinary approach is of particular importance in cancer therapy.
“Genetic information is becoming increasingly important in diagnostics and precision medicine, especially in cancer therapy. Our investment in genomics fits perfectly with our long-term ambition to become a leader in diagnostic information technology. , can have a significant impact on patient care,” says Torbjorn. His Kronander, President and CEO of Sectra, said:
Genomics, the analysis of genetic information, is used in healthcare today to improve patient understanding and diagnosis, and to predict how individual patients will respond to different treatments. Personalized medicine based on genetic information, often called precision medicine, is a rapidly growing field.
To harness the potential of precision medicine and address the dramatic increase in patient data, tomorrow’s diagnostic IT solutions will integrate multidisciplinary information, including genomics, into healthcare with support for integrated diagnostic workflows. must be provided to the provider.
Sektra and University of Pennsylvania health system based on Philadelphialaunched a collaboration to facilitate the development of effective IT solutions.
The new business unit is part of Sectra’s business area, Business Innovation, Fredrik LyshomPh.D. in Bioinformatics.
The genomic information IT solution will become part of Sectra’s enterprise imaging solution, providing an integrated strategy for all imaging needs while reducing operational costs. A scalable and modular solution with VNA at its core, healthcare providers can grow from academic to academic and enterprise to enterprise. Visit Sectra’s website to learn more about Sectra and why we’re ranked #1 in ‘Best in KLAS’.
About Sektra
Sektra contributes to healthier, safer societies by supporting healthcare systems around the world to improve the efficiency of care and by supporting authorities and defense forces. Europe Protect society’s most sensitive information. The company was founded in his 1978 and is headquartered in Linkoping. Sweden, direct sales in 19 countries, and distribution partners worldwide. Total sales for 2021/2022 SEK 1,949 millionSektra’s shares are traded on the Nasdaq Stockholm Exchange. For more information, visit his website at Sectra.
For more information, please contact:
Dr. Torbjörn Kronander, President and CEO, Sectra AB, +46 (0) 705 23 52 27
This information was provided by Cision http://news.cision.com.
https://news.cision.com/sectra/r/sectra-extends-medical-diagnostics-business-to-include-genomics-it,c3622957
You can download the following files:
SOURCE Sectra
.
